CMS‑121
Experimental brain-protective compound: slowed features of aging and Alzheimer's disease in mice, not proven in humans.
Pharmacology
Contents
DETAILED OVERVIEW
What is CMS-121?
CMS-121 is an experimental compound: a modified, lab-made version of fisetin, a plant substance. It was designed to protect brain cells against damage and aging. It is not an approved medicine anywhere, and it is not a dietary supplement either.
It blocks two enzymes that take part in making fatty acids in cells. As a result, the fats in the cells are damaged less, inflammation in the nervous system falls, and levels of acetyl-CoA rise; this substance plays a part in the cell's energy production and in the activity of memory-related genes. In mice it slowed features of aging and Alzheimer's disease, improved memory and thinking, and showed protective effects in metabolic problems. So far it has mainly been studied in animals and is not proven in humans. There is no human safety data, and its safety in pregnancy and breastfeeding has not been established.
Mechanism
Blocks two fatty acid-making enzymes; raises acetyl-CoA level
Evidence
Preclinical (entering early human trials)
Origin
Fisetin derivative (Salk Institute)
No anecdote collected yet.
Receptor profile
- Fatty acid synthase (FASN)Strong
- Acetyl-CoA carboxylase 1 (ACC1)Moderate
- Oxytosis / ferroptosis and neuroinflammationModerate
Safety
Side effects, stop signs, contraindications
Side effects · 4
- No published human safety data: evidence comes almost entirely from mouse and cell-based preclinical studies
- FASN and ACC1 inhibition could theoretically affect lipid metabolism, but the clinical relevance in humans is unknown
- Oral bioavailability, tissue distribution and long-term toxicity in humans are uncharacterized
- Experimental, unapproved drug candidate with an unknown side-effect spectrum
Contraindications · 4
- Pregnancy and breastfeeding: safety not established, avoid
- Not an approved medicine: not recommended for human use without clinical supervision
- Unknown drug interactions with agents affecting lipid metabolism or mitochondrial function
- Children and adolescents: no data, avoid
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia.
Currais A, Raschke W, Maher P, et al.
CMS121: a novel approach to mitigate aging-related obesity and metabolic dysfunction.
Dafre AL, Schubert D, Maher P, et al.
CMS121 Partially Attenuates Disease Progression in Mouse Models of Huntington's Disease.
Ates G, Currais A, Maher P, et al.
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice.
Zahid S, Dafre AL, Currais A, et al.
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease.
Ates G, Goldberg J, Currais A, Maher P
Elevating acetyl-CoA levels reduces aspects of brain aging.
Currais A, Huang L, Goldberg J, et al.
FAQ
FAQ
CMS-121 is an experimental compound engineered from a plant substance called fisetin, designed to protect brain cells from damage and aging. In animal studies it reduced cell-damaging processes and improved memory, but this is an early-stage lab candidate: there's no human data yet, so it shouldn't be treated as an established remedy.
Telegram
Have a question about CMS‑121?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.